查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1742538

急性腎損傷治療市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Acute Kidney Injury Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 199 Pages | 商品交期: 2-10個工作天內

價格

急性腎損傷治療市場-報告範圍

TMR 的全球急性腎損傷治療市場報告研究了過去和當前的成長趨勢和機遇，旨在深入了解 2025 年至 2035 年預測期內的市場指標。該報告提供了 2019 年至 2035 年期間全球急性腎損傷治療市場的收入，以 2025 年為基準年，2035 年為預測。該報告還提供了 2025 年至 2035 年全球急性腎損傷治療市場的年複合成長率(CAGR%)。

本報告經過廣泛的調查後編寫。主要研究工作包括分析師對關鍵意見領袖、產業領導者和輿論領袖進行訪談。次要研究則參考了主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解急性腎損傷治療市場。

市場概況
2024 年的市場價值 36億美元
2035年的市場價值 82億美元
複合年成長率 7.8%

本報告深入探討了全球急性腎損傷治療市場的競爭格局。該報告確定了全球急性腎損傷治療市場的主要參與者，並根據不同屬性對每家公司進行了分析。本報告對全球急性腎損傷治療市場參與者的屬性進行了分析，包括公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2035年全球急性腎損傷治療市場分析與預測

第5章：關鍵見解

  • 管道分析
  • 重點產品及品牌分析
  • 各國/地區監管情況
  • 全球主要國家疾病盛行率及發生率
  • 全球主要國家 AKI 類型死亡率
  • 新興趨勢 - 按 AKI 類型分類
    • 新藥臨床試驗 (IND) - MTX652
    • 使用 iNPC 衍生的細胞外囊泡 (EV) 治療 AKI
    • 早期 AKI 診斷的生物標記
    • 連續性腎臟替代療法（CRRT）進展
    • 腎臟修復中的基因治療
    • 西司他丁預防腎毒素引起的急性腎損傷
    • 治療急性腎損傷 (AKI) 的候選藥物 - UNI-494
    • RMC-035-IND（新藥研究）
    • 人工智慧在 AKI 中的應用
    • 間質幹細胞治療
  • 競爭對手產品的基準化分析
  • 波特五力分析
  • PESTEL分析
  • 對新進者​​（主要是 OEM）的限制/挑戰和主要考慮因素及商業模式的見解

第6章：全球市場分析與預測：按藥物療法

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年藥物治療市場價值預測
    • 血管收縮劑
    • 正性肌力藥物
    • 利尿劑
    • 靜脈注射（IV）晶體溶液
    • 免疫抑制藥物
    • 其他
  • 藥物治療的市場吸引力

第7章：全球市場分析與預測：依類型

  • 介紹和定義
  • 主要發現/進展
  • 2020-2035年各類型市場價值預測
    • 腎前性急性腎損傷
    • 腎內性急性腎損傷
    • 腎後性急性腎損傷
  • 不同類型的市場吸引力

第8章：全球市場分析與預測：按配銷通路

  • 介紹和定義
  • 主要發現/進展
  • 2020-2035年配銷通路市場價值預測
    • 醫院藥房
    • 零售藥局
    • 網路藥局
  • 配銷通路的市場吸引力

第9章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第10章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區

第12章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 亞太其他地區
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 各公司市佔率分析（2024 年）
  • 公司簡介
    • AM-Pharma
    • Aptabio Therapeutics
    • Arch Biopartners
    • Novartis AG
    • Guard Therapeutics
    • Renibus Therapeutics
    • Mission Therapeutics
    • Unicycive Therapeutics Inc.
    • Baxter International Inc.
    • ICU Medical
    • B. Braun Melsungen AG
    • Fresenius Kabi
    • Amanta Healthcare
    • Pfizer, Inc.
    • Sanofi SA
Product Code: TMRGL67523

Acute Kidney Injury Treatment Market - Scope of Report

TMR's report on the global acute kidney injury treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global acute kidney injury treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute kidney injury treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the acute kidney injury treatment market.

Market Snapshot
Market Value in 2024US$ 3.6 Bn
Market Value in 2035US$ 8.2 Bn
CAGR7.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global acute kidney injury treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global acute kidney injury treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global acute kidney injury treatment market.

The report delves into the competitive landscape of the global acute kidney injury treatment market. Key players operating in the global acute kidney injury treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global acute kidney injury treatment market profiled in this report.

Key Questions Answered in global acute kidney injury treatment Market Report:

  • What is the sales/revenue generated by acute kidney injury treatment across all regions during the forecast period?
  • What are the opportunities in the global acute kidney injury treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Acute Kidney Injury Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global acute kidney injury treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global acute kidney injury treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global acute kidney injury treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Acute Kidney Injury Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product & Brand Analysis
  • 5.3. Regulatory Scenario by Country/Region
  • 5.4. Disease Prevalence & Incidence Rate globally with key countries
  • 5.5. Mortality Rate by Type of AKI- globally with key Countries
  • 5.6. Emerging Trends - By Type of AKI
    • 5.6.1. Investigational New Drug (IND) - MTX652
    • 5.6.2. Extracellular Vesicle (EV) Therapy for AKI using iNPC-derived EV
    • 5.6.3. Biomarkers for Early AKI Diagnosis
    • 5.6.4. Continuous Renal Replacement Therapy (CRRT) Advancements
    • 5.6.5. Gene Therapy in Kidney Repair
    • 5.6.6. Prevention Of NephroToxin induced Acute Kidney injury with Cilastatin
    • 5.6.7. Drug Candidate For the Treatment of AKI - UNI-494
    • 5.6.8. RMC-035-IND (Investigational New Drug)
    • 5.6.9. Artificial Intelligence in AKI
    • 5.6.10. Mesenchymal Stem Cell Therapy
  • 5.7. Benchmarking of the Products Offered by the Competitors
  • 5.8. Porter's Five Forces Analysis
  • 5.9. PESTEL Analysis
  • 5.10. Insights on Restraints/Challenges & Major Factors for Considerations & Business Models for New Entrants (Mainly OEMs)

6. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Drug Therapy

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Therapy, 2020-2035
    • 6.3.1. Vasoconstrictor Agents
    • 6.3.2. Inotropic Drugs
    • 6.3.3. Diuretics
    • 6.3.4. Intravenous (IV) Crystalloid Solution
    • 6.3.5. Immunosuppressive Drugs
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Drug Therapy

7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Type, 2020-2035
    • 7.3.1. Pre-renal Acute Kidney Injury
    • 7.3.2. Intrinsic renal Acute Kidney Injury
    • 7.3.3. Post-renal Acute Kidney Injury
  • 7.4. Market Attractiveness By Type

8. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Acute Kidney Injury Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 10.2.1. Vasoconstrictor Agents
    • 10.2.2. Inotropic Drugs
    • 10.2.3. Diuretics
    • 10.2.4. Intravenous (IV) Crystalloid Solution
    • 10.2.5. Immunosuppressive Drugs
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Type, 2020-2035
    • 10.3.1. Pre-renal Acute Kidney Injury
    • 10.3.2. Intrinsic renal Acute Kidney Injury
    • 10.3.3. Post-renal Acute Kidney Injury
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Therapy
    • 10.6.2. By Type
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Acute Kidney Injury Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 11.2.1. Vasoconstrictor Agents
    • 11.2.2. Inotropic Drugs
    • 11.2.3. Diuretics
    • 11.2.4. Intravenous (IV) Crystalloid Solution
    • 11.2.5. Immunosuppressive Drugs
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Type, 2020-2035
    • 11.3.1. Pre-renal Acute Kidney Injury
    • 11.3.2. Intrinsic renal Acute Kidney Injury
    • 11.3.3. Post-renal Acute Kidney Injury
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Therapy
    • 11.6.2. By Type
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Acute Kidney Injury Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 12.2.1. Vasoconstrictor Agents
    • 12.2.2. Inotropic Drugs
    • 12.2.3. Diuretics
    • 12.2.4. Intravenous (IV) Crystalloid Solution
    • 12.2.5. Immunosuppressive Drugs
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Type, 2020-2035
    • 12.3.1. Pre-renal Acute Kidney Injury
    • 12.3.2. Intrinsic renal Acute Kidney Injury
    • 12.3.3. Post-renal Acute Kidney Injury
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Therapy
    • 12.6.2. By Type
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country / Sub-region

13. Latin America Acute Kidney Injury Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 13.2.1. Vasoconstrictor Agents
    • 13.2.2. Inotropic Drugs
    • 13.2.3. Diuretics
    • 13.2.4. Intravenous (IV) Crystalloid Solution
    • 13.2.5. Immunosuppressive Drugs
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Type, 2020-2035
    • 13.3.1. Pre-renal Acute Kidney Injury
    • 13.3.2. Intrinsic renal Acute Kidney Injury
    • 13.3.3. Post-renal Acute Kidney Injury
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Therapy
    • 13.6.2. By Type
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 14.2.1. Vasoconstrictor Agents
    • 14.2.2. Inotropic Drugs
    • 14.2.3. Diuretics
    • 14.2.4. Intravenous (IV) Crystalloid Solution
    • 14.2.5. Immunosuppressive Drugs
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Type, 2020-2035
    • 14.3.1. Pre-renal Acute Kidney Injury
    • 14.3.2. Intrinsic renal Acute Kidney Injury
    • 14.3.3. Post-renal Acute Kidney Injury
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Therapy
    • 14.6.2. By Type
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. AM-Pharma
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Aptabio Therapeutics
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Arch Biopartners
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Novartis AG
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Guard Therapeutics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Renibus Therapeutics
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Mission Therapeutics
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Unicycive Therapeutics Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Baxter International Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. ICU Medical
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. B. Braun Melsungen AG
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Fresenius Kabi
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Amanta Healthcare
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Pfizer, Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Financial Overview
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Sanofi S.A.
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Financial Overview
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 02: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 03: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 06: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 07: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 08: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 10: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 11: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 12: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 15: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 16: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 19: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 20: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 23: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 24: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 03: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 04: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Vasoconstrictor Agents, 2020-2035
  • Figure 05: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Inotropic Drugs, 2020-2035
  • Figure 06: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Diuretics, 2020-2035
  • Figure 07: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Intravenous (IV) Crystalloid Solution, 2020-2035
  • Figure 08: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Immunosuppressive Drugs, 2020-2035
  • Figure 09: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by others, 2020-2035
  • Figure 10: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 11: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 12: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Pre-renal Acute Kidney Injury, 2020-2035
  • Figure 13: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Intrinsic renal Acute Kidney Injury, 2020-2035
  • Figure 14: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Post-renal Acute Kidney Injury, 2020-2035
  • Figure 15: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 16: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 17: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 18: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 19: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035
  • Figure 20: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 22: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 23: North America - Acute Kidney Injury Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 25: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 26: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 27: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 27: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 29: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 30: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 31: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 32: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 33: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 34: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 35: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 36: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 37: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 38: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 39: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 40: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 41: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 42: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 43: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 44: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 45: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 46: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 47: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 48: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 49: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 50: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 51: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 52: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 53: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 54: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 55: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 56: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 57: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 58: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 61: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 62: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 63: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 64: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 65: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035